Sep 2026· Journal of physiology and biochemistry· Vol 82· 0 citations· 145 references
Medicine
TL;DR
Key lncRNAs involved in TAM polarization in PDAC are summarized, highlighting their roles in inducing the M2 phenotype and promoting PDAC progression through epigenetic modifications, ceRNA networks, and signal transduction pathways.
Leveraging the MITF-dependent gene signature activated in macrophages, this work sought to address how MITF-associated enhancers are mechanistically influencing PDAC TAM functions as the tumor becomes more advanced and develops chemoresistance.
Debbie K. Ledezma, K. Gulay, Hervé Tiriac et al.· Cancer Research· 0 citations
Curcumin exerts potent anti-EMT effects in PDAC through multi-targeted regulation of signaling pathways, non-coding RNAs, and stromal-tumor interactions.
Hajar Eftekhari, Zahra Tajik, S. Ghafouri-Fard· Cancer Treatment and Researc...· 0 citations
Overall, it is found that the post-transcriptional regulator HuR facilitates immune evasion in PDAC by constraining T-cell function, identifying HuR blockade as a promising therapeutic strategy in combination with immunotherapies.
Yi-Fei Guo, Jennifer M. Finan, Alexandra Q. Bartlett et al.· Cancer immunology research· 0 citations
Current evidence on TAM‐driven chemoresistance in GC is synthesized, highlighting the molecular interplay between TAMs, tumor cells, and stromal components and underscores the potential of TAM‐centric therapies to overcome resistance and improve clinical outcomes.
S. Abdul-Rahman, Abdulkareem Shareef, S. Jyothi et al.· Cell Biology International· 0 citations
Therapeutic N-glycan modulation is highlighted as a promising tumor microenvironment–targeted strategy for PDAC treatment by disrupting tumor–stroma communication and remodeling the tumor microenvironment by disrupting tumor–stroma communication and remodeling the tumor microenvironment.
Hui-Lan Chang, Chin-Chun Chang, Gita Riswana Nawung Rida et al.· Cancer Research· 0 citations
Current insights into exosome-driven macrophage polarization in HCC are summarized, providing a potential immunotherapeutic strategy for restoring antitumor immunity and improving HCC patient prognosis.
An-Nie L. Chen, Minmin Zhu· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.